Publications by authors named "Avril Fitzgerald"

Claim this Profile
T
Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.
Ruben Tavares, Janet E Pope, Jean-Luc Tremblay, Carter Thorne, Vivian P Bykerk, Avril A Fitzgerald

J Rheumatol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort.
Ruben Tavares, Janet E Pope, Jean-Luc Tremblay, Carter Thorne, Vivian P Bykerk, Avril A Fitzgerald

J Rheumatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative urgency for referral from primary care to rheumatologists: the Priority Referral Score.
Avril Fitzgerald, Carolyn de Coster, Stewart McMillan, Ray Naden, Fraser Armstrong

Arthritis Care Res (Hoboken)· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation.
Cheryl C M Barnabe, Sharon A LeClercq, Avril A Fitzgerald

Semin Arthritis Rheum· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priority-setting tools for rheumatology disease referrals: a review of the literature.
Carolyn De Coster, Avril Fitzgerald, Monica Cepoiu,

Clin Rheumatol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
Avril A Fitzgerald, Sharon A Leclercq, Alexander Yan, Joanne E Homik, Charles A Dinarello

Arthritis Rheum· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
Allen J Lehman, John M Esdaile, Alice V Klinkhoff, Eric Grant, Avril Fitzgerald

Arthritis Rheum· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
Walter P Maksymowych, Gian S Jhangri, Avril A Fitzgerald, Sharon LeClercq, Peter Chiu

Arthritis Rheum· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis